SAFE OUTCOMES WITH NOVEL ORAL ANTICOAGULANTS IN OBESE PATIENTS UNDERGOING ELECTRICAL CARDIOVERSION FOR ATRIAL TACHYARRHYTHMIAS
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY(2018)
摘要
Novel oral anticoagulants (NOACs) are used in patients undergoing direct-current cardioversion (DCCV) for atrial fibrillation and atrial flutter (AF/AFL). There are concerns about their efficacy and safety in severely obese patients as volume of distribution is related to weight and few such
更多查看译文
关键词
oral anticoagulants,electrical cardioversion,obese patients
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要